Ronald Li

Ronald Li

Prof. Ronald Li co-founded Novoheart with Professors Kevin Costa (Mount Sinai) and Michelle Khine (UC Irvine), with the vision of revolutionizing drug discovery and development of heart therapeutics with proprietary bioengineered human heart constructs, and the development of these tissues into cell-based regenerative heart therapies with superior safety and efficacy. Prof. Li is also currently Executive Director of Ming-Wai Lau Centre for Reparative Medicine, Karolinksa Institutet (KI), Sweden, with a concurrent professorial cross appointment at the Dr. Li Dak-Sum Research Center, University of Hong Kong (HKU)-KI Collaboration in Regenerative Medicine of HKU.

 

> Novoheart

Comments are closed